Transient disappearance of CD19(+)/CD5(+) B‐lymphocyte clone in peripheral blood in a patient with CLL during SARS‐CoV‐2‐related mild disease

Although lymphopenia is currently considered a good predictor for the prognosis of COVID‐19, it must be critically evaluated in patients with CLL, where other clinical markers should be considered to define the prognosis and treatment.

Detalles Bibliográficos
Autores principales: Barnabei, Remo, Di Michele, Giulio, Cellini, Antonio, Amicosante, Gianfranco, Perilli, Mariagrazia, Bellio, Pierangelo, Piccirilli, Alessandra, Celenza, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218322/
https://www.ncbi.nlm.nih.gov/pubmed/34188925
http://dx.doi.org/10.1002/ccr3.4238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218322/
https://www.ncbi.nlm.nih.gov/pubmed/34188925
http://dx.doi.org/10.1002/ccr3.4238

Ejemplares similares